Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-25 @ 4:15 AM
Ignite Modification Date:
2025-12-26 @ 3:15 AM
NCT ID:
NCT02724020
Group ID:
EG002
Title:
Arm C: Combination of MLN0128 4 mg QD + MLN1117 200 mg QD
Description:
MLN0128 4 mg and MLN1117 200 mg capsules, orally, both once daily for 3 days per week (QD X 3) on Days 1-3, 8-10, 15-17, and 22-24 of a 28-day treatment cycle until disease progression, unacceptable toxicity, consent withdrawal, death, or transfer to the PTA program (Median duration of treatment was 9.43 weeks up to end of study).
Deaths Number Affected:
19
Deaths Number At Risk:
None
Serious Number Affected:
15
Serious Number At Risk:
31
Other Number Affected:
31
Other Number At Risk:
31
Study:
NCT02724020
Results Section:
NCT02724020
Adverse Events Module:
NCT02724020